Presentation of research results at the 81st Annual Meeting of the Japanese Cancer Association on Thursday, September 29

September 07th, 2022 | Press Release

Research results will be presented at the upcoming Annual Meeting of the Japanese Cancer Association regarding the analysis of the selective delivery mechanism of the drug delivery technology "pullulan nanogel", which is the foundation of our company, to tumor-associated macrophages and its application to cancer treatment drugs. “Pullulan Nanogel Selectively Delivers Drugs to Tumor-Associated Macrophages by Binding to Its Receptor, DC-SIGN (Search for target molecules of CHP nanogel as tumor- associated macrophage-targeted DDS and Development of novel immunotherapy)” Our presentation will be held at the poster presentation venue on Thursday, September 29.

Back to Press releases

We want to provide you with the most important information and services in the best possible way. In order to do this, we need your consent to use the web analysis tool »Google Analytics« to create and evaluate an anonymous analysis of your visit for statistical purposes. You can change your consent at any time on the data protection page, otherwise it will remain valid for twelve months.